B cell lineage marker

B cells are white blood cells that, along with T cells, form the adaptive immune system. They are responsible for antibody production and antigen-presenting to the T cells to generate an effective immune response and contribute to the generation of long-term immunological memory. B cell development goes through several stages, each having a different structure and function; the rearrangement in immunoglobulin loci in the B cell development stage results in the generation and expression of different receptors. Each B cell has a B cell antigen receptor with unique specificity [1]. A series of events leads to B cell activation and the formation of plasma cells. The B cell development and maturation is a complex process; disruption in B cell development or function can cause various autoimmune and immunodeficiency diseases, including melanomas. Thus, understanding the B cell subtype is important for vaccines and targeted therapies.

B-cell lineage marker antibody panel -now customizable

Biomarker SDC1 MS4A1 MME CR2 CD22 CD19
Catalog-No. TA813767S

30 ul

SDC1 mouse monoclonal antibody, clone OTI3G1

TA800385S

30 ul

MS4A1 (CD20) mouse monoclonal antibody, clone OTI4B4 (formerly 4B4)

UM870128

30 ul

MME/CD10 mouse monoclonal antibody, clone UMAB236

TA814111S

30 ul

CD21 mouse monoclonal antibody, clone OTI9D9

TA506412S

30 ul

CD22 mouse monoclonal antibody, clone OTI4C3 (formerly 4C3)

TA506236S

30 ul

CD19 mouse monoclonal antibody, clone OTI3B10

Add To Cart
Add To Cart
Add To Cart
Add To Cart
Add To Cart
Add To Cart
select all

B cell Development

Fig 1. Stem cell differentiation from bone marrow [6].

B cells differentiate from pluripotent hematopoietic stem cells (pHSC) in the bone marrow and fetal liver under different stimuli [2]. The B cell development process starts when multipotent progenitor cells migrate into the fetal liver and the bone marrow. These progenitor cells differentiate into lymphoid progenitor (pro-B cell) cells that give rise to common lymphoid-2 progenitor (LCA-2), the first stage of immature B cells. B cells development depends on BM stromal cells; LCA-2 receives signals from the BM cells for B cell development, including IL-7, Flt3-L, PU.1, IKAROS, EA2, EBF, PAX5, IRF8, etc. [1,2,3,4,5].

B cells go through a series of development stages in the bone marrow and develop antigen specificity. It is marked as one of the most critical steps in B cell development. Each B cell has a B cell antigen receptor (BCR) with unique specificity. The B cells undergo rearrangement of Ig gene segments for broad selectivity and specificity of the adaptive immune system. Ig molecules are composed of 2 identical heavy chains and two light chains. The heavy and light chain loci are composed of different gene elements: variable (V), diversity (D) segment (for heavy chain gene only), constant (C) region, and joining (J). B cell proliferation, differentiation, and gene rearrangement give rise to different B cell subsets.

B cell maturation

Immature B cells, or B cell precursors, exit the bone marrow after their development to enter the peripheral blood circulation as transitional B cells, which can migrate to various secondary lymphoid tissues, such as lymph nodes or spleen. In some cases, some immature B cells remain in the bone marrow to transform into memory B cells. Transitional B cells are the intermediate B cells between immature and mature B cells; they provide a large pool of B cells with diverse antigen specificity. Three groups of transitional B cells, T1, T2, and T3, are classified based on their cell surface marker expression and function. Transitional B cell maturation occurs in the spleen. Transitional B cells undergo a selection process, where they are tested for their ability to bind to self-antigens and antigens. Those that bind poorly or bind to self-antigens are eliminated to avoid autoimmunity. In contrast, those that bind well to antigens undergo further differentiation and maturation into mature, functional B cells: Follicular(FO), marginal (MZ), and germinal center (GC) B cells.

Key CD markers expressed in B cells

There are several markers for studying different stages of B cell differentiation. View the list all markers below:

Our experts have chosen the key markers to study the entire B- cell lineage. The markers and their function is given below:

Name Function B Cell Subtype Expression Localization
CD10 CD10 regulates several cellular processes, including cell adhesion, cell activation, and signal transduction, Pre B cell, Immature B cell, GC B cell Cell membrane
CD19 Co-receptor for the B cell receptor (BCR) complex and is essential for B cell signaling and activation. Pan B cell Cell membrane
CD20 Functions as a membrane-embedded Ca2+?channel, regulates B cell activation and proliferation Mature B cells, Na?ve B cells, GC B cell Cell membrane
CD21 Acts as a receptor for the C3d and epstein-barr virus, interacts with CD19 to induce B cell inflammatory response Mature B cell, Na?ve B cell, Memory B cell, MZ B cell Cell membrane
CD22 Acts as a negative regulator of B cell activation and signaling by recruiting intracellular phosphatases to the B cell receptor (BCR) complex, reducing BCR signaling and activation Mature B cell, Pro B cell, Na?ve B cell Cell membrane
SDC1 Binds to extracellular matrix compartments Plasma Cell Cell membrane

Why study these CD markers for B cell lineage?

CD10

CD10, a common acute lymphoblastic leukemia antigen (CALLA), is a surface protein expressed on various cells, including B cells. CD10 is expressed on a specific subset of B cells, particularly early B cell precursors, including pre-B cells and immature B cells. CD10 expression is regulated during B cell maturation, and its expression decreases as B cells mature. This makes CD10 a valuable marker for tracking B cells? developmental progression and distinguishing between different stages of B cell maturation. In addition to its role as a B cell lineage marker, CD10 has been implicated in several cellular processes, including cell adhesion, cell activation, and signal transduction, making it a valuable target for the development of therapeutic agents for the treatment of B cell-related diseases, such as B cell lymphoma.

Antibodies Proteins Plasmids view all

CD19

CD19 acts as a co-receptor for the B cell receptor (BCR) complex and is essential for B cell signaling and activation. CD19 is also targeted for treating B-cell-related diseases, such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. CD19-directed immunotherapies, such as chimeric antigen receptor (CAR) T cell therapy, have been developed to treat these diseases by targeting and eliminating CD19-expressing B cells.

Antibodies Proteins Plasmids view all

CD20

CD20 is a surface protein expressed on a specific subset of B cells, specifically mature B cells and a subset of pre-B cells. CD20 is expressed on pre-B cells, immature B cells, and mature B cells but not on plasma or memory B cells. CD20 is involved in several cellular processes in B cells, including regulating B cell activation and proliferation. It is also targeted for treating several B cell-related diseases, such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. CD20 is often used as a marker to distinguish B cells from other cell types. Its expression is commonly used to monitor the progression of B cell-related diseases and the efficacy of B cell-directed therapies. Anti-CD20 are frequently being used in the treatment of B cell-related tumors.

Antibodies Proteins Plasmids view all

CD21

CD21 is involved in several cellular processes, including the activation and regulation of B cells. Specifically, CD21 acts as a receptor for the C3d component of complement, which plays a role in the regulation of the adaptive immune response by facilitating the interaction between B cells and T cells. The expression of CD21 on B cells is regulated during B cell maturation, and its expression increases as B cells mature from immature B cells into mature B cells. This makes CD21 a useful marker for tracking B cells? developmental progression and distinguishing between different stages of B cell maturation.

Antibodies Proteins Plasmids view all

CD22

CD22 acts as a negative regulator of B cell activation and signaling by recruiting intracellular phosphatases to the B cell receptor (BCR) complex, reducing BCR signaling and activation. The expression of CD22 on B cells is regulated during B cell maturation, and its expression increases as B cells mature from immature B cells into mature B cells. This makes CD22 a valuable marker for tracking B cells? developmental progression and distinguishing between different stages of B cell maturation.

Antibodies Proteins Plasmids view all

SDC1

Syndecan 1 (Sdc1) is a transmembrane heparan sulfate proteoglycan expressed on the surface of various cell types, including B cells. In B cells, SDC1 is involved in regulating B cell activation and signaling. It acts as a coreceptor for the B cell receptor (BCR) complex and modulates BCR-mediated signaling and activation. SDC1 also regulates B cell adhesion and migration and regulates B cell survival and apoptosis. The expression of SDC1 in B cells is regulated during B cell maturation, and its expression is increased in mature B cells compared to immature B cells. This suggests that SDC1 may play a role in the differentiation of B cells and may be a valuable marker for tracking the developmental progression of B cells.

Antibodies Proteins Plasmids view all

B cell markers

Gene Marker Type Localization
BCL2 Memory B, Plasma Cell Nucleus, Mitochondria
BCL6 Plasma cell Nucleus
CD19 Pan B cells Cell Membrane
CD22 Mature B, Pro B, Na?ve Cell Membrane
CD24 Pan B cells, Breg Cell Membrane
CD27 B1, Memory B, Plasma cell, Plasmablast, Breg Cell Membrane
CD34 Pro B cell, Pre B cell Cell Membrane
CD38 Pro B cell, Pre B cell, Immature B, GC, Plasmablast, Plasma cell, Breg Cell Membrane
CD40 Pan B cells Cell Membrane
CD5 B1, Immature B, Breg Cell Membrane
CD53 Immature B, Na?ve, Memory B Cell Membrane
CD69 Other Cell Membrane
CD72 Pan B cells Cell Membrane
CD80 Memory B, Plasmablast, Activated B Cell Membrane
CD86 Activated B Cell Membrane
CD93 Transitional, Plasmablast, Plasma cell (mouse) Cell Membrane
CD21 Mature B, Na?ve, Memory B, MZ Cell Membrane
CD95 GC, Memory B, Activated B Cell Membrane
CD23 Activated B, Mature B, Na?ve Cell Membrane
CD307d Atypical Memory B Cell Membrane
CD11c Other Cell Membrane
CD9 Pre B cell, Immature B, GC Cell Membrane
CD19 Mature B, Na?ve, GC Cell Membrane
CD72 Memory B Cell Membrane
CD45 Immature B, Na?ve, Memory B, Plasma cell, GC Cell Membrane
SDC1 Plasma cell Cell Membrane
CD43 B1 Cell Membrane
CD71 Breg (human), Memory B Cell Membrane

References

  1. Tob?n, G.J., Izquierdo, J.H. and Ca?as, C.A., 2013. B lymphocytes: development, tolerance, and their role in autoimmunity?focus on systemic lupus erythematosus: autoimmune diseases,?2013.
  2. Melchers, F., 2015. Checkpoints that control B cell development.?The Journal of clinical investigation,?125(6), pp.2203-2210.
  3. Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S33-40. doi: 10.1016/j.jaci.2009.09.017. Epub 2010 Jan 12. PMID: 20061006.
  4. M. Fuxa and J. A. Skok, ?Transcriptional regulation in early B cell development,? Current Opinion in Immunology,vol.19,no. 2, pp. 129?136, 2007
  5. T.W. Lebien and T.F. Tedder, ?B lymphocytes: how they develop and function,? Blood,vol. 112,no.5,pp. 1570?1580,2008
  6. Adapted from ?Stem cell differentiation from bone marrow?, by BioRender.com (2023). Retrieved from https://app.biorender.com/biorender-templates
  7. Mishra D, Singh S, Narayan G. Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis. Mol Biol Int. 2016;2016:4328697. doi: 10.1155/2016/4328697. Epub 2016 Nov 14. PMID: 27965895; PMCID: PMC5124668.
  8. Wang K, Wei G, Liu D. CD19: a biomarker for B cell development, lymphoma diagnosis and therapy. Exp Hematol Oncol. 2012 Nov 29;1(1):36. doi: 10.1186/2162-3619-1-36. PMID: 23210908; PMCID: PMC3520838.
  9. Pavlasova G, Mraz M. The regulation and function of CD20: an "enigma" of B-cell biology and targeted therapy. Haematologica. 2020 Jun;105(6):1494-1506. doi: 10.3324/haematol.2019.243543. PMID: 32482755; PMCID: PMC7271567.
  10. Nielsen CH, Fischer EM, Leslie RG. The role of complement in the acquired immune response. Immunology. 2000 May;100(1):4-12. doi: 10.1046/j.1365-2567.2000.00009.x. PMID: 10809953; PMCID: PMC2326995.
  11. Clark EA, Giltiay NV. CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity. Front Immunol. 2018 Sep 28;9:2235. doi: 10.3389/fimmu.2018.02235. PMID: 30323814; PMCID: PMC6173129.
  12. Sanderson RD, Lalor P, Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1989 Nov;1(1):27-35. doi: 10.1091/mbc.1.1.27. PMID: 2519615; PMCID: PMC361422.